A crowded audience clapping at a conference event

Events

Below is a list of events where Centre of Excellence for Long-acting Therapeutics' (CELT) researchers and staff are presenting CELT research, or events that CELT is endorsing.

a shot from above 12 people all with their hands in the centre of the ring they are stood in.

First meeting of CELT's Community of Practice; Long-acting therapeutics for maternal and paediatric health

23 January 2025, online

Significant gaps currently exist in the development of new medicines for women of child-bearing age and children, compared with the general adult population. This gap could expand further with new treatment modalities like long-acting therapeutics. Additionally, the extent of breastfed infant exposure through breast milk is largely unknown.

The overarching aim of this community of practice (funded by global health agency Unitaid) is to catalyse the development and availability of long-acting therapeutics of value for maternal and paediatric health globally, including in low- and middle- income countries.

This will be achieved through the following specific objectives:

  1. Engaging relevant stakeholders in academia, clinical practice, pharmaceutical industry, regulators, women and patient groups
  2. Synthesise evidence-based perspectives on best practices for long-acting therapeutics
  3. Disseminate outputs from the community of practice for uptake by the wider community.

There will be 9 meetings for the community of practice in 2025 (2 full community of practice meetings online, 1 in person workshop and 6 shorter webinars). The first meeting will be held 12-1.30pm (GMT) on Thursday 23 January. This coincides with ACOG's Maternal Health Awareness Day, whose theme for 2025 is 'Know what's at stake'.

To join the Community of Practice and its first meeting, please fill out this Expression of Interest form to receive an invite link.

We will use this Events page to keep you updated on the remaining events, so please check back. Members are welcome to join the community of practice at any point.

 

The CROI logo is a colour cell with the words

Conference on Retroviruses and Opportunistic Infections (CROI)

9-12 March 2025, San Francisco USA

On Sunday 9 - Wedensday 12 March, CROI will host it's annual conference. The aim is to provide a forum for scientists and clinical investigators to present, discuss, and critique their investigations into the epidemiology and biology of human retroviruses and associated diseases.

We're pleased to say that CELT researchers, Dr Usman Arshad and Dr Henry Pertinez, will be presenting a poster showcasing some exciting preclinical pharmacokinetic research from the LONGEVITY project. As well as CELT staff, LONGEVITY partners University of Nebraska Medical Center will also be presenting LONGEVITY findings at CROI 2025.

Find out more about the conference and registration here.

 

International workshop on long-acting anti-infectives 2025. Abstract submission deadline Friday 28 February 2025. Abstract categories: LA formulations for treatment of infections; Prevention of key infections with LA formulations; regulatory, end user and implementation issues; LA anti-infectives for key populations; future directions and novel platforms for LAAI therapies; monoclonal antibodies.

First International Workshop on Long-acting Anti-infectives (LAAI)

21-22 May 2025, New Orleans USA

CELT endorse this is the first meeting of this workshop, hosted by Academic Medical Education's Virology Education. The LAAI is a platform to advance development, implementation, and scale-up of long-acting anti-infective therapies. The first edition of the workshop will explore the transformative potential of long-acting drug delivery in infectious disease management, with a focus on recent breakthroughs in HIV prevention and treatment.

Find more information about the LAAI workshop, including how to register and submit an abstract.

#LAAIWS

 

Previous events

 

LEAP | New Approaches to Bioequivalence Assessment and Generic Approvals for Long Acting/Extended Release Antiretroviral Formulations

Find all the recordings from the workshop talks here.

LEAP | Long-acting Tuberculosis Drug Development Workshop 2024 - 15 April 2024

Watch CELT co-Director Prof. Andrew Owen's presentation here.

Find all the recordings from the workshop here.

19th Residential Course on Clinical Pharmacology and Antiretrovirals - 17-19 January 2024

Download the presentation decks here

LEAP | Investigator Meeting & Annual Workshop 2023 - 18 February 2023

Update from LONGEVITY delivered by Professor Andrew Owen

Access the full workshop here

LEAP | Investigator Meeting & Annual Workshop 2022 - 12 February 2022

Update from the LEAP Modeling and Simulation Core delivered by Professor Andrew Owen

Update from LONGEVITY delivered by Professor Andrew Owen

Access the full workshop here

LEAP | Investigator Meeting & Annual Workshop 2021 - 5 March 2021

Update from the LEAP Modeling and Simulation Core delivered by Dr Marco Siccardi

Update from LONGEVITY delivered by Professor Andrew Owen

Access the full workshop here

Liverpool Masterclass in Antiretroviral Pharmacology (LMAP) 11 November 2020

PBPK Modelling: No escape from reality delivered by Dr Marco Siccardi

Long-acting antiviral therapy: Life in the slow lane delivered by Professor Andrew Owen

 

Back to: Centre of Excellence for Long-acting Therapeutics